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Background and methods: Nanoparticles engineered to carry both a chemotherapeutic drug 
and a sensitive imaging probe are valid tools for early detection of cancer cells and to monitor 
the cytotoxic effects of anticancer treatment simultaneously. Here we report on the effect of 
size (10–30 nm versus 50 nm), type of material (mesoporous silica versus polystyrene), and 
surface charge functionalization (none, amine groups, or carboxyl groups) on biocompatibility, 
uptake, compartmentalization, and intracellular retention of fluorescently labeled nanoparticles 
in cultured human ovarian cancer cells. We also investigated the involvement of caveolae in 
the mechanism of uptake of nanoparticles.
Results: We found that mesoporous silica nanoparticles entered via caveolae-mediated 
endocytosis and reached the lysosomes; however, while the 50 nm nanoparticles permanently 
resided within these organelles, the 10 nm nanoparticles soon relocated in the cytoplasm. 
Naked 10 nm mesoporous silica nanoparticles showed the highest and 50 nm carboxyl-modified 
mesoporous silica nanoparticles the lowest uptake rates, respectively. Polystyrene nanoparticle 
uptake also occurred via a caveolae-independent pathway, and was negatively affected by 
serum. The 30 nm carboxyl-modified polystyrene nanoparticles did not localize in lysosomes 
and were not toxic, while the 50 nm amine-modified polystyrene nanoparticles accumulated 
within lysosomes and eventually caused cell death. Ovarian cancer cells expressing caveolin-1 
were more likely to endocytose these nanoparticles.
Conclusion: These data highlight the importance of considering both the physicochemical 
characteristics (ie, material, size and surface charge on chemical groups) of nanoparticles and the 
biochemical composition of the cell membrane when choosing the most suitable nanotheranostics 
for targeting cancer cells.
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Introduction
Ovarian cancer is the fifth leading cause of cancer-related deaths among women, and 
the most lethal of the gynecological cancers.1 The high mortality rate in patients with 
ovarian cancer is primarily attributable to late diagnosis, when metastases have already 
formed, and to development of chemoresistant clones that eventually cause relapse.2 
In addition to an intrinsic inability to activate a cell death program,3,4 mechanisms of 
chemoresistance in cancer cells include lysosomal sequestration and inactivation,5 
and enhanced efflux of the toxic drug.6,7 Given the silent nature of the development of 
ovarian cancer and its extreme lethality, there is an urgent need to develop sensitive 
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methods for early diagnosis of primary and secondary 
lesions and novel strategies to deliver cytotoxic drugs to 
chemoresistant clones.
Theranostic nanoparticles engineered to carry both a 
chemotherapeutic drug and a sensitive imaging probe allow 
simultaneous detection of cancer cells and monitoring of the 
cytotoxic effects of anticancer treatment.8–10 Further, such 
nanocarriers can overcome chemoresistance by circumventing 
activation of extruding mechanisms and by protecting the 
drug from lysosomal degradation.11,12 Nanoparticles can reach 
and accumulate within the tumor site passively, exploiting 
leaky and imperfect tumor neovascularization and defective 
lymphatic drainage,13,14 or actively, by functionalizing the 
surface of the nanoparticles with ligands specifically directed 
to targets expressed on tumor cells.15–18
Before a nanomaterial can be deemed a suitable 
theranostic tool, it is necessary to assess its ability to enter 
the cell, to reach the desired intracellular compartment 
(wherein the drug will be liberated), and to remain in the 
cell for a time period sufficient to allow adequate diagnostic 
and therapeutic functions. In this respect, it is convenient to 
select the nanoparticle first for its potential as an “in cell” 
imaging agent and thereafter proceed with its “upgrade’ to 
theranostics by adding a therapeutic function. The purpose of 
the present work was to analyze the potential of mesoporous 
silica and polystyrene nanoparticles as theranostics in 
ovarian cancer by assessing in vitro their uptake, toxicity, 
and intracellular trafficking and stability. Mesoporous 
silica (MCM-41) nanoparticles are emerging as powerful 
nanotheranostic tools because of their porous structure, 
which allows them to host a large number of dye and drug 
molecules and because silica is considered to be safe and 
biodegradable.19–21 While amorphous mesoporous silica 
nanoparticles show poor biocompatibility towards various 
cell types,22–24 mobile composition matter of the MCM-41 
type is well tolerated both in vitro and in vivo.25 Polystyrene 
nanoparticles are also under evaluation for drug delivery and 
cellular imaging.26–29
In this work, we analyzed the mechanism of entry, 
intracellular trafficking, final localization, and biocompatibility 
of fluorescently labeled mesoporous silica and polystyrene 
nanoparticles differing in size and surface charge of chemical 
groups in ovarian cancer cells. In a first set of experiments, 
we compared mesoporous silica nanoparticles 10 ± 5 nm 
diameter, naked (ie, no surface-charged functional group), 
and doped with IRIS-3 dye emitting red fluorescence,30 
with commercial polystyrene nanoparticles 30 ± 10 nm in 
diameter, carboxyl-modified with a negative surface charge, 
and embedded with fluorescein isothiocyanate (FITC) dye 
emitting green fluorescence. In a second set of experiments, 
to get a preliminary insight into the impact of size and 
surface charge groups, we further tested the biocompatibility, 
uptake, and subcellular localization of mesoporous silica 
and polystyrene nanoparticles 50 nm in diameter and 
functionalized (or not) with amine or carboxyl groups.
As a cell model of human ovarian cancer, we initially 
chose the NIHOVCAR3 cell line, which has been shown to 
be resistant to a variety of chemotherapeutics,31 and refractory 
to caveolin-dependent endocytosis of phospholipid-based 
nanocarriers.32,33 Caveolin-1 is the principal constituent of 
caveolae, and acts as an oncosuppressor in ovarian cancer.34 
SKOV3, a human ovarian cancer cell line, has been shown to 
be able to take up various types of nanoparticles in a caveolin-
1-dependent manner. Therefore, the SKOV3 cell line was 
used for the second series of experiments. Schematically, 
we found that: nanoparticles exploited different mechanisms 
of entry, followed different endocytic routes, and showed 
different cellular compartmentalization depending on 
size and type of material; 10 nm naked mesoporous silica 
nanoparticles showed the highest and 50 nm carboxyl-
modified mesoporous silica nanoparticles showed the lowest 
uptake efficiency, independent of caveolin-1 expression; 
30 nm carboxyl-modified polystyrene nanoparticles were 
biocompatible, although not retained intracellularly for a 
long time, and did not enter the acidic endocytic pathway, 
whereas 50 nm amine-modified polystyrene nanoparticles 
accumulated in lysosomes and were toxic. Uptake of 
10 nm mesoporous silica nanoparticles was not affected by 
serum, whereas 30 nm polystyrene nanoparticles was thus 
affected.
Materials and methods
Nanoparticles
The following commercial polystyrene nanoparticles were 
purchased from Sigma-Aldrich (St Louis, MO): 1000 nm 
polystyrene nanoparticles, amine-functionalized, red color-
conjugated (L2778); 50 nm polystyrene nanoparticles, amine-
functionalized, blue color-conjugated (L0780); and 30 nm 
polystyrene nanoparticles, carboxyl-functionalized and 
FITC-conjugated (L5155). The following mesoporous silica 
nanoparticles were provided by Cyanine Technologies SpA 
(Turin, Italy): 10 nm mesoporous silica nanoparticles, naked, 
engrafted with IRIS-3 (IRIS3-Dots-Porous, c3WEL-06); 
50 nm mesoporous silica nanoparticles, naked, engrafted with 
IRIS-3 (IRIS3-Dots, 3DOT.01); 50 nm mesoporous silica 
nanoparticles, amine-functionalized, engrafted with IRIS-3 
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(IRIS Dots-3 amine, 3DOT-03); and 50 nm mesoporous 
silica nanoparticles, carboxyl-functionalized, engrafted with 
IRIS-3 (IRIS Dots-3 carboxyl, 3DOT-02).
Cell culture and treatment
Ovarian NIH-OVCAR3 and SKOV-3 cancer cells were 
cultivated at 37°C with 5% CO
2
 in Dulbecco’s modified Eagle 
Minimum Essential Medium (Sigma-Aldrich) supplemented 
with 10% fetal bovine serum (Lonza Group Ltd, Basel, 
Switzerland) and 100 IU/mL penicillin-streptomycin 
(Sigma-Aldrich). Typically, the cells were plated on sterile 
coverslips and allowed to adhere for 24 hours prior to use. 
The incubations were performed in fresh medium for the time 
indicated. After brief sonication to disrupt conglomerates, 
nanoparticles were dissolved directly in culture medium to 
the desired final concentration.
Cell viability assessment
Cell toxicity was evaluated by checking the metabolic 
activity of the cell. To this end, the cells were loaded with 
the nanoparticles and then labeled with CellTrackerTM (Life 
Technologies Ltd, Paisley, UK), a fluorescent dye that emits 
blue fluorescence of intensity proportional to mitochondrial 
respiratory activity.35 The cells were labeled with 5 µM 
CellTracker for 45 minutes in serum-free medium, and were 
then washed and incubated in regular complete medium for 
30 minutes and observed under the fluorescence microscope. 
As a control for metabolic toxicity, the cells were incubated 
with 1% dimethyl sulfoxide (Sigma Aldrich). Cell viability 
was measured as the percentage of cells labeled with Cell-
Tracker as determined with ImageJ software.
Nanoparticle uptake and intracellular 
trafficking
NIHOVCAR-3 and SKOV-3 cells were plated onto sterile 
coverslips and allowed to adhere for 24 hours. The medium 
was then replaced, and the cells were incubated with the 
nanoparticles for the time indicated. To track the endocytic 
pathway, the cells were prelabeled 10 minutes beforehand 
with Lysotracker Green 100 nM or Red 50 nM (Life 
Technologies Ltd). Alternatively, cells preloaded with 
nanoparticles were subjected to fixation, permeabilization, 
and immunofluorescence staining with anti-Lamp1 antibody, 
which labels both endosomes and lysosomes.36 Incubation at 
4°C was performed on ice with protection from exposure to 
light. The chilled nanoparticles were diluted in either serum-
containing or serum-free medium and added to the cells on 
ice for the time indicated. The cells were then brought back 
to 37°C for recovery, and the endocytosed nanoparticles were 
imaged under a fluorescent microscope (Leica DMI6000, 
Leica Microsystems AG, Wetzlad, Germany) at various 
intervals of recovery. In order to extract cholesterol from the 
plasma membrane, 5 mM of methyl-β-cyclodextrin (MbCD, 
Sigma-Aldrich) was added for 60 minutes in serum-free 
medium prior to incubation with the nanoparticles.
Fluorescence microscope imaging
Samples were observed with the fluorescent microscope, 
keeping the same settings throughout the observations. Five to 
ten fields (minimum 50 cells) were randomly imaged by two 
independent investigators (ME and AG), and representative 
images were chosen for display. Images were captured under 
the fluorescence microscope using the same color intensity 
threshold for all treatments. All images were compiled using 
Adobe Photoshop (the same contrast adjustment was applied 
to all images). Quantification of fluorescent microscope 
images was performed using the ImageJ software freely 
available at http://rsbweb.nih.gov/ij/.
Flow cytometry
Flow cytometry was used to determine the proportion of 
cells that had internalized the nanoparticles. At the end 
of treatment, the cells were washed three times with cold 
phosphate-buffered solution to remove excess nanoparticles, 
and extracellular fluorescence was quenched with 0.4% 
(w/v) Trypan blue in phosphate-buffered solution. The cells 
were then harvested with trypsin, resuspended in phosphate-
buffered solution, and the extent of nanoparticle internaliza-
tion was assessed using a FACScan flow cytometer (Becton 
Dickinson, Franklin Lakes, NJ). Cell-associated fluorescence 
(10,000 cells/sample) was analyzed with WinMID version 
2.9 software.
Western blotting
The standard procedure was used for Western blotting.36 
Briefly, cell homogenates were prepared by dissolving the 
cells in phosphate-buffered solution containing detergents 
and protease inhibitors, followed by freeze-thawing and 
ultrasonication. Aliquots of cell homogenates were denatured 
in Laemmli buffer and resolved by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis. Proteins were then 
transferred onto a nitrocellulose sheet and antigens revealed 
with a mouse monoclonal antibody against caveolin-1 (Becton 
Dickinson) and a monoclonal antibody against β-actin 
(Sigma-Aldrich), using horseradish peroxidase-conjugated 
secondary anti-rabbit IgG and anti-mouse IgG, respectively. 
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The chemoluminescent signal associated with specific bands 
was acquired using the VersaDoc imaging system and Quan-
tity One software (BioRad Laboratories Inc, Hercules, CA).
Statistics
Each experiment was performed in triplicate and reproduced 
at least three times. Quantification data from ImageJ and 
cytofluorometry analyses are shown as the average ± standard 
deviation. The Student’s t-test with P , 0.05 for statistical 
significance was used to compare the results from different 
treatments.
Results
First, we checked whether 10 nm naked mesoporous silica 
and 30 nm carboxyl-modified polystyrene nanoparticles were 
toxic to human ovarian cancer cells. No obviously altered 
morphology or cell loss from the monolayer were observed 
in NIH-OVCAR3 cultures exposed for up to 48 hours to 
either type of nanoparticle at concentrations up to 75 µg/mL 
(Figure 1A). Of note, at this concentration, amine-modified 
polystyrene nanoparticles 1000 nm diameter were extremely 
toxic, underscoring the importance of nanoparticle size in 
cell toxicity (Figure 1A). Cell viability was further tested 
with CellTracker, a thiol-reactive probe that produces a 
stable membrane-impermeable glutathione-fluorescent dye 
adduct in metabolically active cells. CellTracker staining 
enables direct imaging of any metabolic injury in cells loaded 
with nanoparticles.37 Based on the images in Figure 1B, 
after 48 hours of incubation, both mesoporous silica and 
polystyrene nanoparticles (at concentrations of 30 µg/mL and 
75 µg/mL, respectively) exerted no toxic effects on ovarian 
cancer cell metabolism. This conclusion is supported by 
quantitative analysis using ImageJ software.
The fluorescent signal in the images shown in Figure 1B 
indicates that the mesoporous silica nanoparticles accumulated 
in large quantities in NIH-OVCAR3 cells, while only a few 
cancer cells appeared to contain polystyrene nanoparticles, and 
in very small amounts. The latter finding could be explained 
on the basis that polystyrene nanoparticles hardly entered 
the cells, polystyrene-associated fluorescence was rapidly 
and fully quenched within the cellular compartments, or the 
polystyrene nanoparticles were extruded after internalization. 
On the other hand, mesoporous silica nanoparticles were 
also clearly detectable in cells when used at a very low 
concentration (0.5 µg/mL) and for a short duration of 
exposure (5 minutes, Figure 2A). In a typical dose-dependent 
uptake experiment, mesoporous silica nanoparticles were 
shown to almost saturate intracellular compartments 
after only 5 minutes of incubation, at doses starting from 
5 µg/mL. Intracellular accumulation of mesoporous silica 
nanoparticles at 10 µg/mL did not increase with duration 
of incubation, whereas that of polystyrene nanoparticles 
(used at a concentration 7.5-fold that of mesoporous silica 
nanoparticles) increased greatly between 10 and 30 minutes 
of incubation, and a further slight increase occurred between 
30 and 60 minutes (Figure 2B). Quantitative analysis with 
ImageJ software confirmed that while the mesoporous 
silica nanoparticles readily (within 30 minutes) saturated 
the intracellular compartments in almost 90% of the cell 
population, the polystyrene nanoparticles required a longer 
incubation time (.30 minutes) to reach a similar level of 
saturation (data not shown).
For objective measurement of endocytosis rates, we 
directly compared the uptake kinetics of mesoporous silica 
and polystyrene nanoparticles. At the end of each incubation 
time point, the samples were thoroughly washed to remove all 
noninternalized nanoparticles from the cell surface, quenched 
with Trypan blue, and then analyzed by flow cytometry to 
determine the fraction of cells that had internalized into the 
nanoparticles. An aliquot of washed cells was observed under 
the microscope to ascertain the absence of fluorescent nano-
particles passively adsorbed on the cell surface. Flow cytom-
etry data were expressed as the percentage of fluorescently 
labeled cells. Both types of nanoparticles were taken up by 
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Figure 1 Biotolerability of nanoparticles. NIH-OVCAR3 cells adherent on coverslips 
were incubated with 10 nm naked mesoporous silica or 30 nm COOH-polystyrene 
nanoparticles (at the indicated concentration) in fresh medium for 48 hours. 
Thereafter, the monolayers were extensively washed to remove the excess of 
unbound nanoparticles and (A) imaged under the phase-contrast microscope 
to document gross morphological alterations or cell loss, and (B) labeled with 
CellTrackerTM to show metabolic effects. 
Note: Positive control of toxicity was performed by incubating the cells with 1% 
dimethyl sulfoxide.
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the cells, although with differing degrees of efficiency. The 
mesoporous silica nanoparticles entered rapidly and 80% of 
the culture was saturated by 5 minutes, but less than 40% of 
the cell population was labeled by polystyrene nanoparticles 
at this time (Figure 2C). Saturation of approximately 80% of 
the cells with polystyrene nanoparticles was achieved within 
15 minutes of incubation (Figure 2C).
The actual amount of nanoparticles accumulated in the 
cell results from the dynamic interplay between endocytosis 
and exocytosis. Therefore, we sought to assess the 
intracellular retention and exocytosis rates for mesoporous 
silica and polystyrene nanoparticles in ovarian cancer cells 
using a pulse-chase experiment. The cells were incubated 
with the nanoparticles for 15 minutes, ie, sufficient time to 
label the large majority of the cell population. The cells were 
then washed thoroughly and observed under the fluorescence 
microscope at intervals up to 120 minutes to assess visually 
the fluorescent signal retained in the cells. The images in 
Figure 3A show that the mesoporous silica nanoparticles 
persisted in the cells during 120 minutes of chase, whereas 
the fluorescent signal from the polystyrene nanoparticles in 
the cells rapidly (soon after 15 minutes of chase) dropped and 
became only faintly visible by 120 minutes. Quantification 
using ImageJ software confirmed that while the cell-associated 
fluorescent signal of the mesoporous silica nanoparticles 
remained essentially unchanged, the fluorescent signal from 
the polystyrene nanoparticles was reduced by some 80% 
after only 15 minutes of chase (data not shown). A parallel 
cytofluorometry experiment was conducted to quantify the 
proportion of cells labeled with nanoparticles. The results 
of this experiment corroborated the observation reported in 
Figure 3A. Flow cytometry data showed that more than 70% 
of the cells rapidly (within 15 minutes) lost the polystyrene 
nanoparticles, and by 120 minutes only about 5% of the 
cell population was still labeled with these nanoparticles. 
Accurate microscopic observation documented exocytosis 
of the polystyrene nanoparticles from cells after 30 minutes 
of chase. The image in Figure 3C shows the presence of 
polystyrene nanoparticles outside the cells, whereas those few 
remaining inside the cells are mainly located at the extreme 
periphery and beneath the plasma membrane, compatible 
with ongoing exocytosis. Taken together, these data indicate 
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Figure 2 Dose-dependent and time-dependent cellular accumulation of nano-
particles. (A) Cells adherent on coverslips were exposed to different concentrations 
of 10 nm naked mesoporous silica nanoparticles for 5 minutes and imaged by 
fluorescence microscopy. (B) Adherent cells exposed to 10 µg/mL of 10 nm naked 
mesoporous silica nanoparticles or 75 µg/mL of COOH-polystyrene nanoparticles 
for the time indicated as imaged by fluorescence microscopy. (C) Cytofluorometric 
evaluation of labeled cells incubated with 10 µg/mL of 10 nm naked mesoporous 
silica nanoparticles or 75 µg/mL of 30 nm COOH-polystyrene nanoparticles for 
increasing periods of time.
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Figure 3 Mesoporous silica and polystyrene nanoparticles in ovarian cancer cells. 
(A) Adherent cells were incubated in fresh medium with 30 µg of 10 nm naked 
mesoporous silica or 75 µg of 30 nm COOH-polystyrene nanoparticles for 15 minutes. 
The cultures were then thoroughly washed, incubated in fresh medium, and imaged 
at the time indicated. (B) A parallel set of cultures treated as described in (A) was 
used to estimate cell-associated fluorescence by flow cytometry. (C) Cells incubated 
with 75 µg of polystyrene nanoparticles for 15 minutes, washed, and imaged after 
30 minutes of tracking.
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that polystyrene nanoparticles are actively extruded by 
ovarian cancer cells. A separate experiment demonstrated 
that mesoporous silica nanoparticles could instead label the 
cells for up to 72 hours (data not shown). Considering 
that the doubling-time of NIH-OVCAR3 cells under our 
experimental conditions is approximately 20.5 hours, our 
data indicate that, at saturating conditions, mesoporous silica 
nanoparticles are stably retained in ovarian cancer cells and 
can monitor cells for at least three generations.
Different intracellular traffic  
and final localization
Endocytosis brings extracellular material initially to 
early endosomes, then to late endosomes and, eventually, 
to lysosomes.5 To see whether the mesoporous silica 
and polystyrene nanoparticles converged into the same 
intracellular compartments after internalization, we 
coincubated ovarian cancer cells with these nanoparticles 
and followed their intracellular traffic and localization 
at increasing chase times. The cells were exposed to 
the nanoparticles at saturating conditions (30 µg/mL 
mesoporous silica and 75 µg/mL polystyrene, 15 minutes 
of incubation). The monolayer was then promptly and 
thoroughly washed three times with abundant phosphate-
buffered solution and further incubated in fresh culture 
medium for up to 120 minutes. At intervals, a coverslip 
was taken and the monolayer was imaged by fluorescence 
microscopy (Figure 4A). Mesoporous silica nanoparticles 
stably localized in the perinuclear region showing typical 
compartmentalized features in the first 30 minutes of chase 
and cytoplasmic localization in the subsequent period of 
incubation (Figure 4A). Polystyrene nanoparticles were 
clearly visible in the first 30 minutes of tracking, but were 
no longer detectable in the cells by 120 minutes of tracking 
(Figure 4A). Polystyrene nanoparticles showed punctuate 
fluorescence, compatible with intravesicular accumulation, 
which was mainly localized at the extreme periphery of the 
cells (Figure 4A).
It is noteworthy that the mesoporous silica and polystyrene 
nanoparticles never merged, indicating that the two types 
of nanoparticles followed different endocytic routes. To 
characterize the endocytic pathways of mesoporous silica and 
polystyrene nanoparticles, we performed a kinetic study of 
their uptake and intracellular trafficking using Lysotracker 
as a fluorescent tracer of internalization and of intracellular 
acid compartments. To obtain an objective evaluation of the 
labeled vesicles, the two fluorescent signals were quantified 
as individual or merged spots using ImageJ software. 
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Figure 4 Mesoporous silica and polystyrene nanoparticles take different endocytic 
routes and localize to distinct intracellular compartments. (A) Cells adherent on 
coverslips were coincubated for 5 minutes with 30 µg of 10 nm naked mesoporous 
silica nanoparticles and 75 µg of 30 nm COOH-polystyrene nanoparticles. The cells 
were then washed and imaged at 0, 10, 30, and 120 minutes of trace. (B and C) Cells 
adherent on coverslips were preincubated for 10 minutes with Lysotracker Green 
or Red, then washed and incubated with nanoparticles (as indicated), and imaged at 
1, 5, and 30 minutes.
Preliminary experiments indicated that endocytosis and 
intracellular vesicular redistribution of nanoparticles were 
very rapid events. The cells were preloaded with Lysotracker 
for 10 minutes to allow complete labeling of vesicles along the 
endocytic pathway downstream from the lysosomes. Excess 
Lysotracker was washed out, and the cells were labeled 
with nanoparticles and observed under the fluorescence 
microscope at one, 5, and 30 minutes of incubation (note that 
approximately 60–90 seconds were required for extensive 
washing with cold buffer solution and mounting before 
capturing the images). Five to ten fields chosen at random 
were imaged for each sample. Representative images are 
shown in Figure 4B (for mesoporous silica nanoparticles) 
and in Figure 4C (for polystyrene nanoparticles). Digitalized 
images were then analyzed for quantification using ImageJ 
software. Mesoporous silica and Lysotracker showed almost 
complete (94% ± 2%) colocalization at one and 5 minutes 
after labeling and became partially separated by 30 minutes. 
Quantification of cell-associated fluorescence showed that 
more than 98% Lysotracker-positive vesicles were also 
labeled with mesoporous silica nanoparticles at this time, 
while more 90% of mesoporous silica fluorescence was not 
merged with Lysotracker fluorescence. The latter observation 
could reflect loss of signal from Lysotracker Green or a 
physical separation of the two tracers. Indeed, the overall 
fluorescence emission of Lysotracker Green diminished with 
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incubation time. Still, the diffuse localization of mesoporous 
silica fluorescence in the cell favors the interpretation that, 
with time, the 10 nm mesoporous silica nanoparticles 
abandoned the acid compartments. Strikingly, at any time, 
polystyrene nanoparticles colocalized with Lysotracker Red 
(Figure 4C). From these data, we conclude that mesoporous 
silica and polystyrene nanoparticles follow different 
endocytic routes and reach different final compartments in 
the cell.
Different endocytic mechanisms
The observed differences in internalization and retention 
rates of mesoporous silica and polystyrene nanoparticles may 
reflect differences in uptake mechanisms dictated by specific 
physicochemical properties of the nanoparticles. Alternatively, 
mesoporous silica and polystyrene nanoparticles could enter 
the cell via a common endocytosis mechanism and thereafter 
be sorted into different populations of endocytic vesicles.38 
We first checked whether uptake of the nanoparticles occurred 
passively or required energy. To this end, we compared 
the internalization of mesoporous silica and polystyrene 
nanoparticles at 4°C and 37°C. In a typical experiment, the 
cells were incubated for 30 minutes at 4°C with saturating 
concentrations of mesoporous silica (30 µg/mL) or polystyrene 
(75 µg/mL) nanoparticles. Thereafter, the cells were kept at 
37°C and internalization was assessed by microscopic imaging 
at increasing time points (Figure 5A). A parallel set of cultures 
was incubated for 30 minutes at 37°C to serve as a standard 
control for uptake efficiency (Figure 5B). ImageJ software was 
used for quantification. At 0 minutes after recovery at 37°C, the 
uptake of mesoporous silica nanoparticles in culture incubated 
at 4°C was reduced to 90% ± 3% compared with that observed 
in control cultures (assumed to be 100%). Internalization of 
mesoporous silica nanoparticles increased with duration of 
incubation at 37°C, reaching values of 15% ± 3%, 45% ± 5%, 
and 75% ± 5% of control at 5, 10, and 30 minutes, respectively 
(Figure 5A). The uptake of polystyrene nanoparticles was 
apparently not affected by low temperature. In fact, the cell-
associated fluorescence of the polystyrene nanoparticles was 
comparable in cultures incubated at 37°C (controls, Figure 5B) 
and at 4°C (time 0 minutes), and also after recovery at 37°C 
(Figure 5A).
To obtain further objective quantification of temperature-
dependent uptake of the nanoparticles, a parallel set 
of cultures was analyzed by cytofluorometry. The data 
shown in Figure 5C confirm that the uptake of polystyrene 
nanoparticles was not impaired during incubation at 4°C 
followed by recovery at 37°C (compared with uptake at 37°C, 
assumed to be 100%), while that of the mesoporous silica 
nanoparticles was reduced by some 80% at time 0 minutes 
and reached 50% of control values 10 minutes after recovery 
at 37°C. We further investigated the mechanism by which 
the nanoparticles gained entry into the ovarian cancer cells. 
Cholesterol in the plasma membrane has been shown to be 
involved in various cellular uptake mechanisms, including 
those mediated by clathrin, caveolae, and lipid rafts.39 These 
endocytic pathways can be disrupted by selective extraction 
of cholesterol from the plasma membrane imparted by 
MbCD.40 We sought to define whether mesoporous silica and 
polystyrene nanoparticles exploited a cholesterol-dependent 
mechanism of cellular entry. NIH-OVCAR3 cells were or 
were not preincubated for 60 minutes in serum-free medium 
containing 5 mM MbCD, a condition sufficient to deplete 
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Figure 5 Energy-temperature dependence of nanoparticle endocytosis. (A) Cells 
adherent on coverslips were incubated for 30 minutes in the presence of 30 µg of 
10 nm naked mesoporous silica or 75 µg of 30 nm COOH-polystyrene nanoparticles 
at 4°C (on ice). The cells were then washed thoroughly, incubated at 37°C, and 
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at 37°C with 30 µg of mesoporous silica or 75 µg of polystyrene nanoparticles. 
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the plasma membrane of cholesterol. The cells were then 
pulsed for 15 minutes with either type of nanoparticle and, 
after thorough washing, were rapidly observed and imaged 
under the fluorescence microscope. In the control serum-
containing medium, uptake and internal accumulation of 
both nanoparticles in NIH-OVCAR3 cells resembled our 
previous findings, being more efficient for mesoporous 
silica (Figure 5D). Under membrane cholesterol-depleted 
conditions, the uptake of mesoporous silica nanoparticles 
was almost completed prevented, while that of polystyrene 
nanoparticles appeared to be greatly stimulated (Figure 5D). 
It should be noted that incubation in serum-deprived medium 
greatly stimulated the uptake of polystyrene nanoparticles, 
while this condition did not modify the uptake efficiency of 
mesoporous silica nanoparticles (Figure 5D).
Size and charged functional groups affect 
biocompatibility
Finally, we tested the biocompatibility, uptake, and 
intracellular compartmentalization of mesoporous silica 
and polystyrene nanoparticles 50 nm in diameter with or 
without charged functional groups on the surface. The 
uptake and retention efficiency of the nanoparticles, as 
well as their intracellular trafficking, also depend heavily 
on intrinsic cell characteristics, mainly the composition 
and fluidity of the plasma membrane, and the dynamics of 
endocytosis and exocytosis.41 The above data demonstrate 
the relevance of cholesterol in the plasma membrane to 
endocytosis of nanoparticles. Plasma membrane cholesterol 
is a major constituent of caveolae, ie, invaginated regions of 
the plasma membrane that accomplish caveolin-1-dependent 
endocytosis. To determine the involvement of caveolin-1 in 
the nanoparticle uptake mechanism, in this set of experiments 
we included the SKOV3 ovarian cancer cell line. As 
shown by Western blotting, SKOV3 cells highly express 
caveolin-1, whereas this protein is undetectable in NIH-
OVCAR3 cells (Figure 6A). When the 50 nm polystyrene 
nanoparticles functionalized with NH
2
 groups were applied 
to ovarian cancer cultures, cytotoxicity became apparent 
after 4–8 hours (depending on the dose, data not shown). 
A short incubation period (15 minutes) was sufficient to 
reveal that these nanoparticles entered the cells rapidly and 
accumulated within Lysotracker-positive acid compartments 
(Figure 6B). In contrast, the 30 nm COOH-functionalized 
polystyrene nanoparticles continuously added to the culture 
for 24 hours entered both SKOV3 and NIH-OVCAR3 cells 
with similar efficiency, thus showing independence from 
caveolin-1 expression (Figure 6C). These nanoparticles 
were not toxic, even after 24 hours of continuous incubation. 
It is noteworthy that, unlike the 50 nm NH
2
-polystyrene 
nanoparticles, the 30 nm COOH-polystyrene nanoparticles 
never showed overlap with the Lysotracker tracer in the 
acid compartments during 24 hours of incubation, either in 
SKOV3 or in NIH-OVCAR3 cells (Figure 6C). These data 
are in agreement with the data shown in Figure 4, and confirm 
that uptake of 30 nm polystyrene nanoparticles also occurs 
independently of caveolin-1 and does not follow the classic 
acidic endocytosis pathway.
Next, we focused on mesoporous silica nanoparticles. 
Compared with their 10 nm counterparts, the 50 nm 
naked mesoporous silica nanoparticles entered the 
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Figure 6 Size and charged functional groups differentially affect the uptake and 
biocompatibility of mesoporous silica and polystyrene nanoparticles in ovarian cancer 
cells expressing or not expressing caveolin-1. (A) Western blotting of caveolin-1 in 
NIH-OVCAR3 and SKOV3 cells. The filter was reprobed for actin as a reference 
protein for loading of the lanes. The molecular weight of the proteins is indicated. 
Data were reproduced in three independent experiments. (B) Colocalization of 
50 nm amine-modified polystyrene nanoparticles with Lysotracker-positive acid 
compartments in SKOV3 cells after an incubation time of 15 minutes with 75 µg 
of nanoparticles. (C) Comparison of uptake and intracellular localization of 30 nm 
COOH-polystyrene nanoparticles in SKOV3 and NIH-OVCAR cells after incubation 
times of one and 24 hours with 75 µg of nanoparticles. The 30 nm COOH-
polystyrene nanoparticles showed no colocalization with the acid compartment 
tracer, Lysotracker Red. (D) Comparison of uptake and intracellular localization 
of 50 nm mesoporous silica nanoparticles functionalized or not with either COOH 
or NH2 groups in SKOV3 and NIH-OVCAR cells after incubation times of one and 
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Note: Endosomal and lysosomal compartments were identified using the Lamp-1 
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NIH-OVCAR3 cells at a very low rate (Figure 6D). 
SKOV3 cells were more likely to take up these nanoparticles 
(Figure 6D). With regard to surface chemistry, the carboxyl-
modified mesoporous silica nanoparticles showed the least 
entry efficiency in both cell lines (Figure 6D). Altogether, 
the data in Figure 6D indicate that increasing the size from 
10 nm to 50 nm reduces the uptake efficiency of mesoporous 
silica nanoparticles, negatively charged surface groups impair 
endocytosis of mesoporous silica nanoparticles, regardless of 
the presence or absence of caveolin-1 on the plasma mem-
brane, and 50 nm mesoporous silica nanoparticles enter and 
reside permanently in lysosomes.
Discussion
The ideal theranostic nanoparticle is not toxic in itself, is 
biocompatible and biodegradable, is easily and efficiently 
taken up and retained within the cell for the time needed 
to exert its diagnostic and therapeutic function, and safely 
reaches the intracellular compartment of the cancer cell 
where it can release its cytotoxic drug cargo.12 Uptake, 
intracellular trafficking, and biotolerability of nanoparticles 
are greatly influenced by type of material, shape, size, and 
surface charge.23,42 Size is particularly critical for intracellular 
traff icking and the f inal destination of endocytosed 
nanoparticles, given that endocytic compartments range 
between 300 nm and 1000 nm.5 Both the 1000 nm and 50 nm 
amine-modified polystyrene nanoparticles were toxic to 
ovarian cancer cells, while 10 nm and 50 nm mesoporous 
silica and 30 nm carboxyl-modified polystyrene nanoparticles 
exerted no toxic effects on metabolism in ovarian cancer 
cells, consistent with previous reports showing the 
biotolerability of mesoporous silica19,30,37,43 and carboxylated 
polystyrene27,29,44 nanoparticles in other cell types. The 
potentially deleterious effects of nanoparticles on cell 
metabolism depend on their physicochemical characteristics, 
uptake efficiency, and final intracellular destination, as 
well as their accumulation in critical compartments. We 
found that naked mesoporous silica and negatively charged 
polystyrene-COOH nanoparticles were endocytosed and 
retained by NIH-OVCAR3 cells with variable efficiency. 
The 10 nm mesoporous silica nanoparticles showed clear 
vesicular localization when used at low doses (up to 
1 µg/mL), and accumulated in the cytoplasm when used 
at higher concentrations and for longer than 30 minutes, 
suggesting that once the 10 nm nanoparticles have saturated 
the endosomal-lysosomal compartments, leakage toward 
the cytosol may occur. However, 50 nm mesoporous silica 
nanoparticles entered with much lower efficiency and 
localized permanently in lysosomes. On the other hand, 
polystyrene nanoparticles temporarily accumulated in 
recycling endocytic vesicles and therefore showed limited 
intracellular accumulation. The two types of nanoparticles 
never showed overlap of the endocytic routes, in that while 
the mesoporous silica nanoparticles transited through acid 
compartments labeled by Lysotracker, COOH-polystyrene 
nanoparticles followed an endocytic route not labeled by 
Lysotracker. These findings suggest that the two types of 
nanoparticles had different endocytic mechanisms and 
routes which led them to distinct subcellular compartments. 
Lowering the temperature to approximately 4°C completely 
inhibited the uptake of mesoporous silica nanoparticles but 
not that of polystyrene nanoparticles, indicating that entry 
of the former was energy-dependent.
To investigate further the mechanism of nanoparticle 
internalization, we used MbCD, which depletes the plasma 
membrane of cholesterol and thus inhibits clathrin-mediated 
and caveolin-mediated endocytosis.39 Uptake of mesoporous 
silica nanoparticles was largely prevented when the 
cholesterol-dependent endocytic mechanism was disrupted, 
while that of polystyrene nanoparticles apparently increased. 
Because MbCD treatment was given in the absence of serum, 
this increase can be explained with the “protein corona” 
effect.45 This effect consists of reduced internalization of 
nanoparticles due to adsorption of serum protein on the 
surface of the nanoparticle. In effect, uptake of polystyrene 
nanoparticles, but not that of mesoporous silica nanoparticles, 
was higher in the absence of serum than in its presence.
The present data are fully in agreement with a recent report 
by Smith et al.29 Size and surface chemistry have been shown 
to be important characteristics influencing the efficiency 
and mechanism of uptake in various cells.44,46–51 COOH-
polystyrene nanoparticles with a diameter , 200 nm showed 
reduced cell surface binding in the presence of serum,52 which 
results in low uptake efficiency.51 Accordingly, it has recently 
been shown that cellular association and endocytosis of 
20 nm COOH-polystyrene nanoparticles is greatly reduced in 
the presence of serum.29 It has also been shown that regardless 
of the presence or absence of serum, 20 nm COOH-
polystyrene nanoparticles enter cells via clathrin-mediated 
endocytosis.29 The 30 nm COOH-polystyrene nanoparticles 
were very efficiently taken up by SKOV3 cells regardless 
of whether incubation was performed in the presence or 
absence of serum or under membrane cholesterol-depleted 
conditions (data not shown). Thus, in SKOV3 cells, the 
serum “protein corona” did not interfere with the mechanism 
of entry, and the cholesterol-dependent endocytic pathway 
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was not involved in the uptake of polystyrene nanoparticles. 
This latter observation is in agreement with the findings 
of Fazlollalhi et al,53 who showed that transcytosis of 
polystyrene nanoparticles in differentiated MDCK-II cells 
was not mediated by lipid-raft endocytosis. Moreover, 
uptake of 24 nm polystyrene nanoparticles by HeLa and 
human umbilical vein endothelial cells was also shown not 
to be dependent on clathrin or caveolae.26 Consistent with 
our findings, the 30 nm polystyrene nanoparticles in these 
cells were found in recycling vesicles and not labeled with 
Lysotracker.26
Conclusion
In this work, we compared the biotolerability, uptake effi-
ciency, and intracellular trafficking of mesoporous silica and 
polystyrene nanoparticles in cultured ovarian cancer cells. 
This was a pilot study to test the potential for use of these 
nanoparticles as theranostic vehicles in the diagnosis and 
treatment of ovarian cancer.33 The principal findings of this 
study are schematically reported in Table 1. We have shown 
how the size and surface charge on the chemical groups of 
mesoporous silica and polystyrene nanoparticles differentially 
affect uptake, intracellular localization and retention, and 
biocompatibility in ovarian cancer cell lines expressing 
(SKOV-3) or not expressing (NIH-OVCAR3) caveolin-1. 
Endocytosis of COOH-polystyrene 30 nm nanoparticles did 
not follow the classic acid compartment pathway and entered 
recycling vesicles from which the nanoparticles were extruded, 
while the 50 nm amine-modified polystyrene nanoparticles 
accumulated within Lamp-1-positive acid compartments, 
and eventually (after incubation for longer than 8 hours) 
caused cell death. Mesoporous silica nanoparticles 10 nm in 
size rapidly entered the acid compartments and eventually 
accumulated in the cytoplasm, whereas 50 nm mesoporous 
silica nanoparticles permanently resided within lysosomes. 
Internalization of mesoporous silica nanoparticles was energy-
dependent and cholesterol-dependent, and was in general 
(with the exception of COOH-modified nanoparticles) more 
efficient in SKOV3 cells than in NIH-OVCAR3 cells, under-
scoring the role of caveolin-1 in the uptake mechanism. It is to 
be noted that caveolin-1 is depleted or downregulated in the 
vast majority of ovarian carcinomas.34 Therefore, choice of 
the most suitable nanotheranostics for targeting cancer cells 
should take into account the physicochemical characteristics 
of the nanoparticles in relation to the biochemical character-
istics of the cell membrane.
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